These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


476 related items for PubMed ID: 19023372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
    Montoro E, Lemus D, Echemendía M, Armas L, González-Ochoa E, Llanes MJ, Valdivia JA.
    Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
    [Abstract] [Full Text] [Related]

  • 5. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Mar 24; 55(11):301-5. PubMed ID: 16557213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
    Atre SR, Mistry NF.
    J Public Health Policy; 2005 Apr 24; 26(1):96-114. PubMed ID: 15906879
    [Abstract] [Full Text] [Related]

  • 8. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rüsch-Gerdes S, Blok L, Doshetov D.
    PLoS Med; 2006 Oct 24; 3(10):e384. PubMed ID: 17020405
    [Abstract] [Full Text] [Related]

  • 9. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis].
    Yoshiyama T, Ito K, Ogata H, Aono A, Wada M.
    Kekkaku; 2005 Jan 24; 80(1):9-14. PubMed ID: 15839057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Emergence extensive drug resistance tuberculosis (XDR)].
    Vier H, Schaberg T, Gillissen A.
    Pneumologie; 2007 Sep 24; 61(9):606-9. PubMed ID: 17729211
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB, Sotgiu G, Jaramillo E, Mirzayev F, Centis R, Colvin C, Richardson MD.
    Int J Tuberc Lung Dis; 2009 Oct 24; 13(10):1305-8. PubMed ID: 19793438
    [Abstract] [Full Text] [Related]

  • 17. Worldwide emergence of extensively drug-resistant tuberculosis.
    Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP.
    Emerg Infect Dis; 2007 Mar 24; 13(3):380-7. PubMed ID: 17552090
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS.
    Int J Tuberc Lung Dis; 2009 Sep 24; 13(9):1154-60. PubMed ID: 19723407
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.